MAIT cells as attractive vaccine targets

Area of Science:

• Immunology
• Cell Biology
• Microbiology

Background:

• Mucosal-associated invariant T (MAIT) cells are abundant immune cells in humans, particularly in mucosal tissues, blood, liver, and lungs.
• MAIT cells recognize microbial vitamin B metabolites via the MHC class I-related protein-1 (MR1) molecule, mediating innate-like immune responses.
• These cells are implicated in host defense against various pathogens, including bacteria, fungi, and viruses, and are found in tumor microenvironments.

Purpose of the Study:

• To summarize recent advances in understanding MR1-mediated and MR1-independent MAIT cell immune responses.
• To evaluate the potential of MAIT cells in vaccine development by analyzing their strengths and weaknesses.

Main Methods:

• Review and synthesis of current scientific literature on MAIT cell functions and immune responses.
• Analysis of MAIT cell involvement in infectious diseases and cancer.
• Assessment of MAIT cell-derived cytokines and their dual roles in immunity and inflammation.

Main Results:

• MAIT cells exhibit potent anticancer and antibacterial activities through cytokine production.
• MAIT cells are activated during viral infections and may provide protection independently of MR1.
• MAIT cells can also possess pro-inflammatory and potentially tumor-promoting properties.

Conclusions:

• MAIT cells present a complex profile with both beneficial and detrimental functions in immunity and disease.
• Their multifaceted roles necessitate careful consideration in the context of vaccine strategies.
• Further research is required to fully harness MAIT cell potential for therapeutic applications, including vaccine design.